Onconova Therapeutics Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
51
- Investments
-
1
Onconova Therapeutics General Information
Description
Developer of biopharmaceuticals designed for the treatment of respiratory viral diseases and oncology. The company's technology utilizes oral small molecule antiviral agents that target viral enzymes to treat influenza and COVID-19 without metabolic inhibitors, enabling healthcare providers to treat resistant viral strains while minimizing drug-drug interactions and clinical rebound.
Contact Information
Website
www.onconova.comCorporate Office
- 12 Penns Trail
- Newtown, PA 18940
- United States
Corporate Office
- 12 Penns Trail
- Newtown, PA 18940
- United States
Onconova Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Onconova Therapeutics Comparisons
Industry
Financing
Details
Onconova Therapeutics Competitors (62)
One of Onconova Therapeutics’s 62 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Marengo Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Symphogen | Formerly VC-backed | Ballerup, Denmark | ||||
| Incyte | Formerly VC-backed | Wilmington, DE |
Onconova Therapeutics Signals
Onconova Therapeutics Acquisitions (1)
Onconova Therapeutics’s most recent deal was a Reverse Merger with Traws Pharma for . The deal was made on 02-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Traws Pharma | 02-Apr-2024 | Reverse Merger | Drug Discovery |
Onconova Therapeutics Exits (1)
Onconova Therapeutics’s most recent exit was on 02-Apr-2024 from Traws Pharma. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Traws Pharma | 02-Apr-2024 | Completed |
|
Onconova Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Traws Pharma | Newtown, PA | 2021 |
Onconova Therapeutics FAQs
-
When was Onconova Therapeutics founded?
Onconova Therapeutics was founded in 1998.
-
Where is Onconova Therapeutics headquartered?
Onconova Therapeutics is headquartered in Newtown, PA.
-
What is the size of Onconova Therapeutics?
Onconova Therapeutics has 51 total employees.
-
What industry is Onconova Therapeutics in?
Onconova Therapeutics’s primary industry is Biotechnology.
-
Is Onconova Therapeutics a private or public company?
Onconova Therapeutics is a Public company.
-
Who are Onconova Therapeutics’s competitors?
Genentech, AnTolRx, Marengo Therapeutics, Symphogen, and Incyte are some of the 62 competitors of Onconova Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process